Falvo, E.; Arcovito, A.; Conti, G.; Cipolla, G.; Pitea, M.; Morea, V.; Damiani, V.; Sala, G.; Fracasso, G.; Ceci, P.
Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy. Pharmaceutics 2020, 12, 992.
https://doi.org/10.3390/pharmaceutics12100992
AMA Style
Falvo E, Arcovito A, Conti G, Cipolla G, Pitea M, Morea V, Damiani V, Sala G, Fracasso G, Ceci P.
Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy. Pharmaceutics. 2020; 12(10):992.
https://doi.org/10.3390/pharmaceutics12100992
Chicago/Turabian Style
Falvo, Elisabetta, Alessandro Arcovito, Giamaica Conti, Giuseppe Cipolla, Martina Pitea, Veronica Morea, Verena Damiani, Gianluca Sala, Giulio Fracasso, and Pierpaolo Ceci.
2020. "Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy" Pharmaceutics 12, no. 10: 992.
https://doi.org/10.3390/pharmaceutics12100992
APA Style
Falvo, E., Arcovito, A., Conti, G., Cipolla, G., Pitea, M., Morea, V., Damiani, V., Sala, G., Fracasso, G., & Ceci, P.
(2020). Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy. Pharmaceutics, 12(10), 992.
https://doi.org/10.3390/pharmaceutics12100992